1GG5 | Oxidoreductase | date | Jul 12, 2000 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of A Complex Of Human Nad[P]H-Quinone Oxid And A Chemotherapeutic Drug (E09) At 2.5 A Resolution | ||||||||||||||
authors | M.Faig, M.A.Bianchet, S.Winski, R.Hargreaves, C.J.Moody, A.R.Hudn D.Ross, L.M.Amzel | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Nad(P)H Dehydrogenase [Quinone] 1 Chain: A, B, C, D Synonym: Quinone Reductase, Dt-Diaphorase Ec: 1.6.99.2 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
symmetry | Space Group: P 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.50 Å | ||||||||||||
ligand | E09, FAD | enzyme | Oxidoreductase E.C.1.6.99.2 BRENDA | ||||||||||||
related structures | by homologous chain: 1DXO, 1QRD | ||||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Structure-based development of anticancer drugs: complexes of NAD(P)H:quinone oxidoreductase 1 with chemotherapeutic quinones., Faig M, Bianchet MA, Winski S, Hargreaves R, Moody CJ, Hudnott AR, Ross D, Amzel LM, Structure. 2001 Aug;9(8):659-67. PMID:11587640 |
Data retrieval |
View 1GG5 in 3D |
Visual 3D analysis of 1GG5 |
Structure-derived information |
- Domain d1gg5a_, region A [Jmol] [rasmolscript] [script source] - Domain d1gg5b_, region B [Jmol] [rasmolscript] [script source] - Domain d1gg5c_, region C [Jmol] [rasmolscript] [script source] - Domain d1gg5d_, region D [Jmol] [rasmolscript] [script source] |
Sequence-derived information |
Other resources with information on 1GG5 |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |